Medicine and Dentistry
Computer Assisted Tomography
100%
Magnetic Resonance Imaging
89%
Prostate Cancer
63%
Surgery
62%
Breast Cancer
59%
Mammography
56%
Superior Vena Cava Syndrome
56%
BRCA Mutation
56%
Neoplasm
45%
Multiparametric Magnetic Resonance Imaging
45%
Biopsy
35%
Retrospective Study
33%
Breast Imaging - Reporting And Data System
31%
Cancer Diagnosis
30%
Patient with Crohn's Disease
28%
Emergency Department
28%
Coronary Computed Tomography Angiography
28%
Aggressive Fibromatosis
28%
Sarcopenia
28%
Cancer Risk
28%
Digital Breast Tomosynthesis
28%
Bile Duct Dilatation
28%
Cancer Screening
28%
Prospective Study
28%
Prostate Specific Antigen
28%
Anticoagulation
28%
Magnetic Resonance Cholangiopancreatography
28%
Adipose Tissue
28%
Thrombosis
28%
Pancreatectomy
28%
Microsphere
28%
Positron Emission Tomography
28%
Embolization
28%
Doxorubicin
28%
Neoadjuvant Therapy
28%
Tyrosine-Kinase Inhibitor
28%
Colorectal Liver Metastasis
28%
Treatment Effect
28%
Gynecomastia
28%
Hiatus Hernia
28%
Pancreas Adenocarcinoma
28%
Positron Emission Tomography-Computed Tomography
28%
Lobular Carcinoma
28%
Esophagus Carcinoma
28%
Gastrointestinal Tract
28%
BRCA1
25%
Overall Survival
24%
Skeletal Muscle
22%
Computed Tomography Angiography
21%
Lipid Storage
20%
Keyphrases
Prostate Cancer Screening
84%
Malignant Superior Vena Cava Syndrome
56%
Patient Selection
56%
Multiparametric MRI (mpMRI)
46%
Magnetic Resonance Imaging
42%
Computed Tomography
39%
Mutation Carriers
37%
Breast Cancer
37%
Prostate Cancer
34%
Prostate
34%
Breast Imaging
33%
Peripheral Zone
31%
Reporting System
30%
Data Systems
30%
Overall Survival
30%
Screening Mammography
28%
Digital Breast Tomosynthesis
28%
Intra-arterial
28%
BRCA mutation Carriers
28%
Breast Cancer Risk
28%
Contrast-enhanced Mammography
28%
Curative Surgical Resection
28%
Abdominal Aortic Calcification
28%
Anticoagulation
28%
Quantitative Evaluation
28%
Prostate-specific Antigen
28%
Microsphere Embolization
28%
Multi-targeted Tyrosine Kinase Inhibitors
28%
Bile Duct Dilatation
28%
Magnetic Resonance Cholangiopancreatography
28%
Doxorubicin
28%
Intramuscular Adipose Tissue Content
28%
Within-person Research
28%
Thrombosis
28%
Treatment Effect
28%
Qualitative Evaluation
28%
Innovative Diffusion
28%
Screening Population
28%
BRCA mutation
28%
Invasive Lobular Carcinoma
28%
Hormonal Treatment
28%
Hiatal Hernia
28%
Abdominopelvic Computed Tomography
28%
Gynecomastia
28%
Background Parenchymal Enhancement
28%
Desmoid-type Fibromatosis
28%
Esophageal Carcinoma
28%
Age-related Changes
28%
Emergency Department
28%
Colorectal Liver Metastases
28%